Skip to main content
Top
Published in: Pediatric Nephrology 9/2010

01-09-2010 | Letter to the Editors

Letter to the editors regarding comments by Ghirardello et al. on the rasburicase article

Authors: David Hobbs, Gina-Marie Barletta, Jin Chung, Julia Steinke, Timothy Bunchman

Published in: Pediatric Nephrology | Issue 9/2010

Login to get access

Excerpt

Sirs, …
Literature
2.
go back to reference Hobbs DJ, Steinke JM, Chung JY, Barletta GM, Bunchman TE (2010) Rasburicase improves hyperuricemia in infants with acute kidney injury. Pediatr Nephrol 25:305–309CrossRefPubMed Hobbs DJ, Steinke JM, Chung JY, Barletta GM, Bunchman TE (2010) Rasburicase improves hyperuricemia in infants with acute kidney injury. Pediatr Nephrol 25:305–309CrossRefPubMed
3.
go back to reference Goldman SC, Holcenberg JS, Finklestein JZ, Hutchinson R, Kreissman S, Johnson FL, Tou C, Harvey E, Morris E, Cairo MS (2001) A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis. Blood 97:2998–3003CrossRefPubMed Goldman SC, Holcenberg JS, Finklestein JZ, Hutchinson R, Kreissman S, Johnson FL, Tou C, Harvey E, Morris E, Cairo MS (2001) A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis. Blood 97:2998–3003CrossRefPubMed
4.
go back to reference Pui CH, Mahmoud HH, Wiley JM, Woods GM, Leverger G, Camitta B, Hastings C, Blaney SM, Relling MV, Reaman GH (2001) Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients with leukemia or lymphoma. J Clin Oncol 19:697–704PubMed Pui CH, Mahmoud HH, Wiley JM, Woods GM, Leverger G, Camitta B, Hastings C, Blaney SM, Relling MV, Reaman GH (2001) Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients with leukemia or lymphoma. J Clin Oncol 19:697–704PubMed
5.
go back to reference Coiffier B, Mounier N, Bologna S, Fermé C, Tilly H, Sonet A, Christian B, Casasnovas O, Jourdan E, Belhadj K, Herbrecht R, Groupe d’Etude des Lymphomes de l’Adulte Trial on Rasburicase Activity in Adult Lymphoma (2003) Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of hyperuricemia during induction chemotherapy of aggressive non-Hodgkin’s lymphoma: results of the GRAAL1 (Groupe d’Etude des Lymphomes de l’Adulte Trial on Rasburicase Activity in Adult Lymphoma) study. J Clin Oncol 21:4402–4406CrossRefPubMed Coiffier B, Mounier N, Bologna S, Fermé C, Tilly H, Sonet A, Christian B, Casasnovas O, Jourdan E, Belhadj K, Herbrecht R, Groupe d’Etude des Lymphomes de l’Adulte Trial on Rasburicase Activity in Adult Lymphoma (2003) Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of hyperuricemia during induction chemotherapy of aggressive non-Hodgkin’s lymphoma: results of the GRAAL1 (Groupe d’Etude des Lymphomes de l’Adulte Trial on Rasburicase Activity in Adult Lymphoma) study. J Clin Oncol 21:4402–4406CrossRefPubMed
Metadata
Title
Letter to the editors regarding comments by Ghirardello et al. on the rasburicase article
Authors
David Hobbs
Gina-Marie Barletta
Jin Chung
Julia Steinke
Timothy Bunchman
Publication date
01-09-2010
Publisher
Springer-Verlag
Published in
Pediatric Nephrology / Issue 9/2010
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-010-1516-z

Other articles of this Issue 9/2010

Pediatric Nephrology 9/2010 Go to the issue